ArabFinance:Minapharm Pharmaceuticals’ ordinary general assembly approved cash dividends to shareholders of EGP 2.7 per share, according to the company’s filing on April 28th.
The general assembly also ratified the financial statement for 2020.
Minapharm posted a consolidated net profit of EGP 300.78 million in 2020, compared to EGP 414.091 million in 2019.
In late March, the pharmaceutical company acquired 96.79% of Germany-based ProBioGen.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Copyright © 2021 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).